Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients

Background: Cognitive impairment affects 40%–68% of relapsing-remitting multiple sclerosis (RRMS) patients. Gray matter (GM) demyelination is complicit in cognitive impairment, yet cortical lesions are challenging to image clinically. We wanted to determine whether cortical cerebral blood flow (CBF), cerebral blood volume (CBV), and mean transit time (MTT) differences exist between cognitively impaired (CI) and unimpaired (NI) RRMS. Methods: Prospective study of healthy controls (n = 19), CI (n = 20), and NI (n = 19) undergoing magnetic resonance imaging (MRI) and cognitive testing <1 week apart. White matter (WM) T2 hyperintense lesions and T1 black holes were traced. General linear regression assessed the relationship between lobar WM volume and cortical and WM CBF, CBV, and MTT. Relationship between global and lobar cortical CBF, CBV, and MTT and cognitive impairment was tested using a generalized linear model. Adjusted Bonferroni p < 0.005 was considered significant. Results: No significant differences for age, gender, disease duration, and any fractional brain or lesion volume were demonstrated for RRMS subgroups. Expanded Disability Status Scale (EDSS) and Hospital Anxiety and Depression Scale–Depression (HADS-D) were higher in CI. Lobar cortical CBF and CBV were associated with cognitive impairment (p < 0.0001) after controlling for confounders. Cortical CBV accounted for 7.2% of cognitive impairment increasing to 8.7% with cortical CBF (p = 0.06), while WM and cortical CBF accounted for 8.2% of variance (p = 0.04). Conclusion: Significant cortical CBF and CBV reduction was present in CI compared to NI in the absence of structural differences.

[1]  S. T. Govindarajan,et al.  A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. , 2015, Brain : a journal of neurology.

[2]  F. Cendes,et al.  Subclinical MRI disease activity influences cognitive performance in MS patients. , 2015, Multiple sclerosis and related disorders.

[3]  Jeff H. Duyn,et al.  7 Tesla Magnetic Resonance Imaging to Detect Cortical Pathology in Multiple Sclerosis , 2014, PloS one.

[4]  A. Kunkel,et al.  Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study , 2014, BMJ Open.

[5]  Charlotte Graham,et al.  Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  F. Barkhof,et al.  Cognitive impairment in MS , 2013, Neurology.

[7]  A. Gass,et al.  Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis , 2013, Multiple sclerosis.

[8]  John J. Lee,et al.  Cerebrovascular occlusive disease: quantitative cerebral blood flow using dynamic susceptibility contrast mr imaging correlates with quantitative H2[15O] PET. , 2013, Radiology.

[9]  Alessandra Bertoldo,et al.  Heterogeneity of Cortical Lesions in Multiple Sclerosis: An MRI Perfusion Study , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  A. Feinstein,et al.  Robust Perfusion Deficits in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis , 2013, American Journal of Neuroradiology.

[11]  D. Louis Collins,et al.  Quantitative Magnetic Resonance Imaging of Cortical Multiple Sclerosis Pathology , 2012, Multiple sclerosis international.

[12]  M. Calabrese,et al.  Cortical lesion load associates with progression of disability in multiple sclerosis. , 2012, Brain : a journal of neurology.

[13]  A. Feinstein,et al.  Decreased Frontal Lobe Gray Matter Perfusion in Cognitively Impaired Patients with Secondary-Progressive Multiple Sclerosis Detected by the Bookend Technique , 2012, American Journal of Neuroradiology.

[14]  P. Matthews,et al.  Increased PK11195 PET binding in the cortex of patients with MS correlates with disability , 2012, Neurology.

[15]  R. Reynolds,et al.  Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis , 2012, Multiple sclerosis.

[16]  Alessandra Bertoldo,et al.  Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. , 2011, Radiology.

[17]  F. Barkhof,et al.  Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis , 2011, Multiple sclerosis.

[18]  M. Cambron,et al.  Vascular aspects of multiple sclerosis , 2011, The Lancet Neurology.

[19]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[20]  M. Calabrese,et al.  Magnetic resonance evidence of cortical onset of multiple sclerosis , 2009, Multiple sclerosis.

[21]  G. Johnson,et al.  White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis , 2009, Journal of the Neurological Sciences.

[22]  M. Filippi,et al.  Cortical lesions in primary progressive multiple sclerosis , 2009, Neurology.

[23]  J. De Keyser,et al.  Hypoperfusion of the Cerebral White Matter in Multiple Sclerosis: Possible Mechanisms and Pathophysiological Significance , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  G. Johnson,et al.  Perfusion Magnetic Resonance Imaging Correlates of Neuropsychological Impairment in Multiple Sclerosis , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Wanyong Shin,et al.  Quantitative cerebral perfusion using dynamic susceptibility contrast MRI: Evaluation of reproducibility and age‐ and gender‐dependence with fully automatic image postprocessing algorithm , 2007, Magnetic resonance in medicine.

[26]  Marco Battaglini,et al.  Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. , 2007, Archives of neurology.

[27]  Glyn Johnson,et al.  Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. , 2007, Archives of neurology.

[28]  R. Rudick,et al.  Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients , 2006, Annals of neurology.

[29]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[30]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[31]  M R Symms,et al.  Abnormalities of cerebral perfusion in multiple sclerosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[32]  J. DeLuca,et al.  The relationship between depressive symptoms and cognitive dysfunction in multiple sclerosis , 2003, Cognitive neuropsychiatry.

[33]  S. Morrow,et al.  Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS. , 2016, The Journal of neuropsychiatry and clinical neurosciences.

[34]  E. Làdavas,et al.  Education protects against cognitive changes associated with multiple sclerosis. , 2013, Restorative neurology and neuroscience.